Troubled $3B Cancer Agency meets Amid New Scrutiny

Leaders of an embattled $3 billion cancer-fighting agency in Texas are meeting for the first time since disclosing that a lucrative state grant was improperly awarded to a private company.

The Cancer Prevention and Research Institute of Texas faces questions from top lawmakers after spending much of the year under a barrage of criticism. The agency's woes intensified when it was revealed that a Dallas biomedical company won $11 million in taxpayer funds without having its proposal vetted by experts.

The agency's governing board meets Wednesday. Among the agenda items is a report from the compliance officer who uncovered the improper grant to Peloton Therapeutics.

Gov. Rick Perry and other key Republicans last week called on the agency to explain how and why Peloton's proposal was never reviewed.

Lawmakers Advance Teacher Residency Program

We ask that the following Community Standards be followed:

Comments must not be profane or vulgar.

Comments must not use hate speech, racial slurs, or violent descriptions.

We encourage varying views to be shared. We do ask commenters to not personally attack other readers, groups, people featured in our stories, or other posters for disagreeing with their views.

Comments must not contain negative, comparative debates between community standards of cities or towns.

Comments must contribute to the discussion, flaming and/or trolling will not be tolerated.

Comments must be truthful and not intentionally falsified. Providing a source link is encouraged.

If you find that a comment violates the above rules, please use the flagging option located to the right of the comment to notify the moderators.
For a complete list of guidelines, please follow this link:
http://www.kbtx.com/home/misc/Online-Commenting-Policy-181579421.html